Fibrocell Science is an autologous cell and gene therapy company, focusing on discovering and developing therapies for diseases affecting the skin, connective tissues and joints. The Company’s gene-therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, which is in pre-clinical development stage for the treatment of linear scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions.

TypePublic
HQExton, US
Founded1995
Size (employees)20 (est)-13%
Websitefibrocell.com
Fibrocell Science was founded in 1995 and is headquartered in Exton, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Fibrocell Science

John Maslowski

John Maslowski

President and Chief Executive Officer
Pamela Swiggard

Pamela Swiggard

Vice President of Regulatory Affairs and Quality Assurance
Sean Buckley

Sean Buckley

Vice President of Business Administration and Corporate Secretary
Show more

Fibrocell Science Office Locations

Fibrocell Science has an office in Exton
Exton, (HQ)
405 Eagleview Boulevard
Show all (1)
Report incorrect company information

Fibrocell Science Financials and Metrics

Fibrocell Science Revenue

Fibrocell Science's revenue was reported to be $355 k in FY, 2016 which is a 27.8% decrease from the previous period.
USD

Net income (Q2, 2018)

(5.8m)

EBIT (Q2, 2018)

(6.1m)

Market capitalization (4-Dec-2018)

19.6m

Closing stock price (4-Dec-2018)

2.1

Cash (30-Jun-2018)

15.4m
Fibrocell Science's current market capitalization is $19.6 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

200.0k180.0k492.0k355.0k

Revenue growth, %

(10%)173%(28%)

Cost of goods sold

8.1m722.0k697.0k

Gross profit

(7.9m)(230.0k)(342.0k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

194.0k137.0k79.0k16.0k87.0k215.0k

Cost of goods sold

1.9m793.0k547.0k512.0k147.0k162.0k204.0k18.0k392.0k287.0k

Gross profit

47.0k(25.0k)(125.0k)(2.0k)(305.0k)(72.0k)

Gross profit Margin, %

24%(18%)(158%)(12%)(351%)(33%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

60.0m37.5m29.3m17.5m17.4m

Accounts Receivable

Inventories

597.0k1.3m482.0k

Current Assets

61.9m39.3m31.0m18.0m17.9m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

16.9m54.0m49.5m44.2m33.3m26.9m36.9m13.1m8.2m21.3m20.6m15.9m11.9m12.2m15.4m

Inventories

574.0k506.0k476.0k610.0k544.0k484.0k566.0k475.0k109.0k

Current Assets

19.2m55.5m50.7m45.3m34.9m28.1m38.0m14.6m8.9m21.7m21.1m16.4m12.2m12.7m15.9m

Total Assets

26.3m62.4m57.4m51.9m41.2m34.1m43.9m20.2m10.5m23.2m22.7m18.0m13.8m14.1m17.3m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(31.6m)(25.6m)(34.5m)(15.3m)(16.2m)

Depreciation and Amortization

863.0k883.0k767.0k564.0k384.0k

Inventories

(120.0k)26.0k89.0k126.0k

Accounts Payable

2.0m(1.8m)(114.0k)(139.0k)69.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Net Income

(25.0m)(14.0m)(16.3m)(22.3m)(8.5m)(15.3m)(16.8m)(1.4m)(9.5m)(11.8m)(5.0m)(19.0m)(19.1m)(2.9m)(5.8m)

Depreciation and Amortization

693.0k222.0k452.0k673.0k140.0k346.0k554.0k391.0k91.0k184.0k

Inventories

(97.0k)91.0k121.0k(13.0k)27.0k87.0k5.0k475.0k222.0k482.0k

Accounts Payable

248.0k(2.1m)(1.6m)(1.9m)774.0k833.0k1.5m893.0k(3.0k)(212.0k)(55.0k)192.0k132.0k23.0k51.0k
USDY, 2018

Financial Leverage

1.8 x
Show all financial metrics
Report incorrect company information

Fibrocell Science Online and Social Media Presence

Embed Graph
Report incorrect company information

Fibrocell Science Company Life and Culture

Report incorrect company information

Fibrocell Science Frequently Asked Questions

  • When was Fibrocell Science founded?

    Fibrocell Science was founded in 1995.

  • Who are Fibrocell Science key executives?

    Fibrocell Science's key executives are John Maslowski, Pamela Swiggard and Sean Buckley.

  • How many employees does Fibrocell Science have?

    Fibrocell Science has 20 employees.

  • Who are Fibrocell Science competitors?

    Competitors of Fibrocell Science include BioSpecifics Technologies, Y-mAbs Therapeutics and Vitrisa Therapeutics.

  • Where is Fibrocell Science headquarters?

    Fibrocell Science headquarters is located at 405 Eagleview Boulevard, Exton.

  • Where are Fibrocell Science offices?

    Fibrocell Science has an office in Exton.

  • How many offices does Fibrocell Science have?

    Fibrocell Science has 1 office.